By Joan S. McClure, MS, Senior Vice President, Clinical Information & Publications
On Wednesday, March 9, the National Comprehensive Cancer Network® (NCCN®) conducted the 2011 NCCN Fellows Recognition Program: New Horizons in Quality Cancer Care™, with more than 200 fellows from around the country participating in the program. Attendees primarily included medical oncology fellows; however, a significant minority was made up of radiation oncologists in training. The program provides fellows with an opportunity to meet leading faculty from NCCN Member Institutions and to attend a series of lectures targeted specifically to specialists in training.
This year, the NCCN Fellows Recognition Program focused on the management of several types of cancer, with each presentation addressing specific issues important across disease sites. The program began with a discussion of the management of advanced breast cancer by Clifford Hudis, MD, of Memorial Sloan-Kettering Cancer Center. Dr. Hudis used the topic to illustrate how to critically evaluate clinical trials data.
Asher Chanan-Khan, MD, of Roswell Park Cancer Institute, discussed management of multiple myeloma, including use of various imaging modalities to evaluate disease. Michael Wong, MD, PhD, of University of Southern California Norris Comprehensive Cancer Center, discussed the use of tyrosine kinase inhibitors (TKIs) in treating several types of cancer. Dr. Wong provided insight into how TKIs work, assessment of their effectiveness and failure, and their differences from conventional therapy.
Gregory Otterson, MD, of the Ohio State University Comprehensive Cancer Center ̶ James Cancer Hospital and Solove Research Institute, provided insight into the multidisciplinary management of locoregional non-small cell lung cancer. Dr. Otterson focused on the methods of patient evaluation and their interpretation in selection of primary therapy.
Finally, the evolving role of medical informatics in the practice of oncology was discussed by Ephraim Hochberg, MD, of Massachusetts General Hospital, and Mia Levy, MD, PhD, of Vanderbilt-Ingram Cancer. Dr. Hochberg focused on the use of tools in managing quality in oncology practice, while Dr. Levy focused on the array of tools currently available to physicians to support clinical decision making.Throughout the program, participating fellows discussed the presentations with faculty, demonstrating the promise of the new generation of oncologists.